Celestica (CLS)
Celestica R&D Expense: 3.20M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CLS R&D Expense Rankings
| Overall | 52nd percentile | 841 of 1785 |
| Sector | 66th percentile | 219 of 649 in Technology |
| Industry | 33rd percentile | 6 of 9 in Printed Circuit Boards |
CLS R&D Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2007 |
| Maximum | 4.70M | Dec 2011 |
| Average | 0.85M |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these CLS related companies
CLS News
Deutsche Bank Downgrades Celestica (CLS) to Hold; Valuation Call After Recent Run
Apr 16, 5:25PM Street Insider
Apr 16, 5:25PM Street Insider
$CLS - exceeded its one year target ($10.25) today's high $10.34
about 70 days ago by stocktradez
about 70 days ago by stocktradez
$CLS entered trade - made another 30 day high today. Nice gapped open!
about 85 days ago by stocktradez
about 85 days ago by stocktradez
$CLS -I've been watching this one as it climbs. I decided to go with LSI instead due to S&P Performance, but may enter this one too.
about 94 days ago by stocktradez
about 94 days ago by stocktradez
Celestica Announces TSX Approval of Previously Announced Normal Course Issuer Bid
Feb 07, 5:37PM PR Newswire
Feb 07, 5:37PM PR Newswire
$CLS 200 Day SMA Cross - Price crossed above 200 day SMA (8.5247). Confirmed by volume.
about 114 days ago by TradeIdeasQuant
about 114 days ago by TradeIdeasQuant
Biggest analyst upgrades/downgrades for Cdn stks last 4 weeks http://stks.co/oz0 $CLS $AEM
about 211 days ago by ScottAdams_Edit
about 211 days ago by ScottAdams_Edit
Celestica downgraded to Sector Perform from Outperform at Scotia Capital
Oct 21, 9:21AM FlyOnTheWall
Oct 21, 9:21AM FlyOnTheWall
A market beating strategy for hunting for deals amongst heavily-shorted stocks http://stk.ly/maewXJ via @globeandmails $CLS $RCI
about 332 days ago by ScottAdams_Edit
about 332 days ago by ScottAdams_Edit
A short-sellers’ hunting ground for Canadian stocks http://stk.ly/jM2zc3 via @globeandmail $CLS
about 339 days ago by ScottAdams_Edit
about 339 days ago by ScottAdams_Edit
RIM fallout: Celestica downgraded http://stk.ly/jmYVQT via @globeandmail $CLS $RIMM
about 343 days ago by ScottAdams_Edit
about 343 days ago by ScottAdams_Edit
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CLS | 7.56 | +0.04 | +0.53% | 1.486B |
| CLNE | 13.96 | -0.08 | -0.57% | 1.204B |
| CLI | 27.36 | +0.13 | +0.48% | 2.391B |
| CL | 99.15 | +0.76 | +0.77% | 47.19B |
| CITZ | 5.35 | +0.00 | +0.00% | 58.42M |
| CIT | 35.16 | +0.84 | +2.45% | 7.060B |
| CII | 12.75 | +0.10 | +0.79% | |
| CIG | 17.16 | +0.13 | +0.76% | 14.64B |
| CIDM | 1.505 | +0.01 | +0.33% | 56.46M |
| CHW | 8.13 | +0.05 | +0.62% |
